Puerarin is effective in ameliorating obesity-associated lipid metabolism disorders and gut microbiota dysbiosis, largely by activating hepatic FXR signaling and restoring FXR-mediated homeostasis. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.